heins News

RIM co-CEOs step down, COO Heins now taking over BlackBerry maker

According to recent reports, the co-CEOs of BlackBerry creator Research in Motion, Mike Lazaridis and Jim Balsillie, are stepping down from positions they've held for more than two decades. COO Thorsten Heins will now take over RIM.

In the Media by David Silverberg - 2 comments

Set up a news alert for

heins

Top News

	Vibrating news: Panel rules two-armed vibrator patent infringed
	Op-Ed: Julian Assange has served his time
	Netanyahu warned of economic threats of stalled peace process
	Australian woman sounds French after car accident [video]
	Teen claims TSA told her 'you're only 15, cover up'
	Sugar overload is dangerous for the heart
	Op-Ed: Russia agrees to support a coalition government in Syria
	Ice-T narrates 'Assaulted: Civil Rights Under Fire' Documentary
	Iran defeats South Korea 1-0, moves on to World Cup
	Miami Heat snatch Game 6 in overtime 103-100
	Montreal mayor Applebaum resigns amid fraud charges
	Afghans assume security as Taliban opens Qatar office, talks loom
	Watch Wendy's customer lose it over cheese on his burger
	Video: Popocatépetl volcano shoots out ash, incandescent rocks
	Obama appoints prominent attorney to close down Guantanamo
	Op-Ed: Could you see Pierre Trudeau taking money to speak to a charity?
	Op-Ed: Unlocking the Truth proves age doesn't matter in metal
	'Standing man' becomes latest symbol of Turkey protests
	Toronto welcomes touring sculptures by Ai WeiWei Special
	Malian Government signs peace treaty with Tuareg rebels
	3-billion-yr-old ancient water tastes salty scientist says
	Time for Morro Bay Aquarium to close, say conservation groups
	American Medical Association recognizes obesity as a disease
	NASA wants you to help find killer-asteroids
	No breakthrough on Assange in meeting between Patiño and Hague
	Snowflake, famous albino gorilla was inbred, DNA sequencing shows
	Op-Ed: The benefits of being nobody in Turkey Special
	UK politician Simon Parkes fathered a child with alien Cat Queen
	'Sharpshooter' cancer drug ready for human trials, stops cancer
	250,000 people protest in cities across Brazil